Sean A. McCarthy - 26 Mar 2024 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
26 Mar 2024
Net transactions value
+$172,874
Form type
4
Filing time
28 Mar 2024, 19:12:49 UTC
Previous filing
21 Mar 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Options Exercise $172,874 +109,768 +21% $1.57 634,249 26 Mar 2024 Direct F1
holding CTMX Common Stock 93,158 26 Mar 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -109,768 -100% $0.000000* 0 26 Mar 2024 Common Stock 109,768 $1.57 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 197,500 restricted stock units.
F2 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F3 This option is fully vested and exercisable.
F4 The Reporting Person previously transferred 9,768 shares subject to this stock option to a family member.